Caplacizumab Model-Based Dosing Recommendations in Pediatric Patients With Acquired Thrombotic Thrombocytopenic Purpura [2]

J Clin Pharmacol. 2022 Mar;62(3):409-421.
Bergstrand M, Hansson E, Delaey B, Callewaert F, Sousa RP, Sargentini-Maier ML.
HematologyJournalMIDDPharmacometricsSpecial/specific populations

Pharmetheus Affiliates

Portrait-of-Emma-Hansson_Pharmetheus
Senior Director, Regulatory Affairs

Emma Hansson

See bio
Portrait-of-Martin-Bergstrand_Pharmetheus
Principal Director, MIDD Scientific Lead

Martin Bergstrand

See bio
Portrait-of-Viviana-Moroso-Pharmetheus-1
Director, Quality Control & Medical Writing Consultant

Viviana Moroso

See bio